1620 Investment Advisors »

United Therapeutics Corporation shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $123k 386 318.55

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Tri Continental Corporation Etf (TY)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
TJX Companies (TJX)
Apple (AAPL)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
Eaton (ETN)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Citigroup
Geode Capital Management
FMR
LSV Asset Management
Morgan Stanley
AQR Capital Management
Dimensional Fund Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation